BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 16323968)

  • 1. Xerostomia secondary to Sjögren's syndrome in the elderly: recognition and management.
    Al-Hashimi I
    Drugs Aging; 2005; 22(11):887-99. PubMed ID: 16323968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral health status, related behaviours and perceived stress in xerostomia, Sicca and Sjögren's syndromes patients - a cross-sectional study.
    Stankeviciene I; Stangvaltaite-Mouhat L; Aleksejuniene J; Mieliauskaite D; Talijuniene I; Butrimiene I; Bendinskaite R; Puriene A
    BMC Oral Health; 2024 Apr; 24(1):454. PubMed ID: 38622697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and management of dry mouth and its complications in rheumatology practice.
    Khavandgar Z; Warner BM; Baer AN
    Expert Rev Clin Immunol; 2024; 20(1):1-19. PubMed ID: 37823475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Sjogren's syndrome presenting as an isolated severe autonomic dysfunction treated with steroids.
    Kataria R; Suja L; Anil AA; Senthil N
    BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38087488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effectiveness of a novel intra-oral electro-stimulator for the treatment of dry mouth in patients with Sjogren's syndrome: A randomised sham-controlled feasibility study (LEONIDAS-1).
    Fedele S; Al-Hamad A; Mercadante V; Porter S; Isenberg D; Poveda-Gallego A; Brown ST
    J Oral Pathol Med; 2023 Aug; 52(7):619-627. PubMed ID: 37220073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidemiology of Sjögren's syndrome.
    Patel R; Shahane A
    Clin Epidemiol; 2014; 6():247-55. PubMed ID: 25114590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary Manifestations of Sjögren's Disease.
    Byrne L; McCarthy C; Fabre A; Gupta N
    Semin Respir Crit Care Med; 2024 Jun; 45(3):397-410. PubMed ID: 38621712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raman hyperspectroscopy of saliva and machine learning for Sjögren's disease diagnostics.
    Vyas B; Khatiashvili A; Galati L; Ngo K; Gildener-Leapman N; Larsen M; Lednev IK
    Sci Rep; 2024 May; 14(1):11135. PubMed ID: 38750168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subacute Progressive Hearing Loss and Lower Body Parkinsonism in Primary Sjögren's Syndrome.
    Shimizu M; Fujimaki M; Igami E; Ishiguro Y; Noda K; Okuma Y; Hattori N
    Intern Med; 2024 Mar; 63(6):853-856. PubMed ID: 37495532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to translational research in Sjögren's syndrome with childhood onset: challenges of recognising and diagnosing an orphan rheumatic disease.
    Ciurtin C; Cho Y; Al-Obaidi M; Jury EC; Price EJ
    Lancet Rheumatol; 2021 Feb; 3(2):e138-e148. PubMed ID: 38279369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A relatively rare traditional Chinese medicine pattern of primary Sjögren syndrome: A case report.
    Chen Q; Chen X; Zhu Y; Yu X
    Medicine (Baltimore); 2024 Apr; 103(15):e37744. PubMed ID: 38608118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between vitamin B12, iron, folic acid, homocystein and vitamin D3 serum levels in orofacial sicca and/or Sjögren's syndrome in a Hungarian patient population].
    Tóth G; Erdei C; Dézsi A; Németh O; Kovács A; Kiss EV; Márton K
    Orv Hetil; 2024 Jan; 165(4):147-154. PubMed ID: 38281197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the Aetiophatogenesis of Sjögren's Syndrome: a Literature Review.
    Gomes Pde S; Juodzbalys G; Fernandes MH; Guobis Z
    J Oral Maxillofac Res; 2012 Apr; 3(1):e2. PubMed ID: 24422004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging biologic frontiers for Sjogren's syndrome: Unveiling novel approaches with emphasis on extra glandular pathology.
    Li XX; Maitiyaer M; Tan Q; Huang WH; Liu Y; Liu ZP; Wen YQ; Zheng Y; Chen X; Chen RL; Tao Y; Yu SL
    Front Pharmacol; 2024; 15():1377055. PubMed ID: 38828450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidisciplinary Therapeutic Approach of a Patient With Sjogren's Syndrome: A Three-Year Follow-Up Study.
    Kokoti M; Zisis V; Andreadis D; Bakopoulou A
    Cureus; 2024 Feb; 16(2):e55148. PubMed ID: 38558652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigative biological therapies for primary Sjögren's syndrome.
    He SH; Xuan YY; Liang X; Guo KJ; Wang Y; Fu XN; Li TF
    Arch Med Sci; 2024; 20(2):506-516. PubMed ID: 38757038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision medicine in Sjögren's disease.
    Gandolfo S; Bombardieri M; Pers JO; Mariette X; Ciccia F
    Lancet Rheumatol; 2024 May; ():. PubMed ID: 38723653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sjögren's syndrome with lymphocytic interstitial pneumonia: A case report.
    Zhu B; Wang H; Ma D; Liu H
    Asian J Surg; 2024 Mar; ():. PubMed ID: 38480094
    [No Abstract]   [Full Text] [Related]  

  • 19. Area postrema syndrome secondary to primary Sjogren's syndrome.
    Chen W; Chen W; Yan R
    Rheumatol Adv Pract; 2024; 8(2):rkae031. PubMed ID: 38505768
    [No Abstract]   [Full Text] [Related]  

  • 20. CRESS: improving the assessment of disease activity in Sjögren's syndrome.
    Isenberg DA
    Lancet Rheumatol; 2021 Aug; 3(8):e534-e535. PubMed ID: 38287613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.